Salt la conţinut

Chirurgie cardiotoracică şi vasculară

Managementul și inversarea anticoagulării

Prothrombin complex concentrates versus fresh frozen plasma for warfarin reversal. A systematic review and meta-analysis. (se deschide o fereastră nouă)

Chai-Adisaksopha C, Hillis C, Siegal DM, Movilla R, Heddle N, Iorio A, Crowther M.

Sursă‎: Thromb Haemost 2016;116(5):879-90.

Index‎: PubMed 27488143

DOI‎: 10.1160/TH16-04-0266

https://www.ncbi.nlm.nih.gov/pubmed/27488143 (se deschide o fereastră nouă)

Reversal of warfarin: case-based practice recommendations. (se deschide o fereastră nouă)

Garcia DA, Crowther MA.

Sursă‎: Circulation 2012;125(23):2944-7.

Index‎: PubMed 22689931

DOI‎: 10.1161/CIRCULATIONAHA.111.081489

https://www.ncbi.nlm.nih.gov/pubmed/22689931 (se deschide o fereastră nouă)

Stopping antiplatelet medication before coronary artery bypass graft surgery: is there an optimal timing to minimize bleeding? (se deschide o fereastră nouă)

Gielen CL, Bruggemans EF, Stijnen T, Eikenboom J, Tavilla G, Brand A, Klautz RJ.

Sursă‎: Eur J Cardiothorac Surg 2015;48(4):e64-70.

Index‎: PubMed 26248820

DOI‎: 10.1093/ejcts/ezv269

https://www.ncbi.nlm.nih.gov/pubmed/26248820 (se deschide o fereastră nouă)

Is a fully heparin-bonded cardiopulmonary bypass circuit superior to a standard cardiopulmonary bypass circuit? (se deschide o fereastră nouă)

Mahmood S, Bilal H, Zaman M, Tang A.

Sursă‎: Interact Cardiovasc Thorac Surg 2012;14(4):406-14.

Index‎: PubMed 22228288

DOI‎: 10.1093/icvts/ivr124

https://www.ncbi.nlm.nih.gov/pubmed/22228288 (se deschide o fereastră nouă)

Heparin-bonded circuits versus nonheparin-bonded circuits: an evaluation of their effect on clinical outcomes. (se deschide o fereastră nouă)

Mangoush O, Purkayastha S, Haj-Yahia S, Kinross J, Hayward M, Bartolozzi F, Darzi A, Athanasiou T.

Sursă‎: Eur J Cardiothorac Surg 2007;31(6):1058-69.

Index‎: PubMed 17306555

DOI‎: 10.1016/j.ejcts.2007.01.029

https://www.ncbi.nlm.nih.gov/pubmed/17306555 (se deschide o fereastră nouă)

Idarucizumab for dabigatran reversal. (se deschide o fereastră nouă)

Pollack CV Jr, Reilly PA, Eikelboom J, Glund S, Verhamme P, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kamphuisen PW, Kreuzer J, Levy JH, Sellke FW, Stangier J, Steiner T, Wang B, Kam CW, Weitz JI.

Sursă‎: N Engl J Med 2015;373(6):511-20.

Index‎: PubMed 26095746

DOI‎: 10.1056/NEJMoa1502000

https://www.ncbi.nlm.nih.gov/pubmed/26095746 (se deschide o fereastră nouă)

Idarucizumab for dabigatran reversal - full cohort analysis. (se deschide o fereastră nouă)

Pollack CV Jr, Reilly PA, van Ryn J, Eikelboom JW, Glund S, Bernstein RA, Dubiel R, Huisman MV, Hylek EM, Kam CW, Kamphuisen PW, Kreuzer J, Levy JH, Royle G, Sellke FW, Stangier J, Steiner T, Verhamme P, Wang B, Young L, Weitz JI

Sursă‎: N Engl J Med 2017;377(5):431-41.

Index‎: PubMed 28693366

DOI‎: 10.1056/NEJMoa1707278

https://www.ncbi.nlm.nih.gov/pubmed/28693366 (se deschide o fereastră nouă)

Platelet mapping and desmopressin reversal of platelet inhibition during emergency carotid endarterectomy. (se deschide o fereastră nouă)

Ranucci M, Nano G, Pazzaglia A, Bianchi P, Casana R, Tealdi DG.

Sursă‎: J Cardiothorac Vasc Anesth 2007;21(6):851-4.

Index‎: PubMed 18068065

DOI‎: 10.1053/j.jvca.2007.05.009

https://www.ncbi.nlm.nih.gov/pubmed/18068065 (se deschide o fereastră nouă)

Protective effects of tranexamic acid on clopidogrel before coronary artery bypass grafting: a multicenter randomized trial. (se deschide o fereastră nouă)

Shi J, Ji H, Ren F, Wang G, Xu M, Xue Y, Chen M, Qi J, Li L.

Sursă‎: JAMA Surg 2013;148(6):538-47.

Index‎: PubMed 23426385

DOI‎: 10.1001/jamasurg.2013.1560

https://www.ncbi.nlm.nih.gov/pubmed/23426385 (se deschide o fereastră nouă)

Andexanet alfa for the reversal of Factor Xa inhibitor activity. (se deschide o fereastră nouă)

Siegal DM, Curnutte JT, Connolly SJ, Lu G, Conley PB, Wiens BL, Mathur VS, Castillo J, Bronson MD, Leeds JM, Mar FA, Gold A, Crowther MA.

Sursă‎: N Engl J Med 2015;373(25):2413-24.

Index‎: PubMed 26559317

DOI‎: 10.1056/NEJMoa1510991

https://www.ncbi.nlm.nih.gov/pubmed/26559317 (se deschide o fereastră nouă)

Recombinant factor VIIa (rFVIIa) and hemodialysis to manage massive dabigatran-associated postcardiac surgery bleeding. (se deschide o fereastră nouă)

Warkentin TE, Margetts P, Connolly SJ, Lamy A, Ricci C, Eikelboom JW.

Sursă‎: Blood 2012;119(9):2172-4.

Index‎: PubMed 22383791

DOI‎: 10.1182/blood-2011-11-393587

https://www.ncbi.nlm.nih.gov/pubmed/22383791 (se deschide o fereastră nouă)

Heparinized cardiopulmonary bypass circuits and low systemic anticoagulation: an analysis of nearly 6000 patients undergoing coronary artery bypass grafting. (se deschide o fereastră nouă)

Øvrum E, Tangen G, Tølløfsrud S, Skeie B, Ringdal MA, Istad R, Øystese R.

Sursă‎: J Thorac Cardiovasc Surg 2011;141(5):1145-9.

Index‎: PubMed 20709334

DOI‎: 10.1016/j.jtcvs.2010.07.003

https://www.ncbi.nlm.nih.gov/pubmed/20709334 (se deschide o fereastră nouă)